Walleye Trading LLC Halozyme Therapeutics, Inc. Transaction History

Walleye Trading LLC

$52.6 Billion
Q2 2025

A detailed history of Walleye Trading LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 300 shares of HALO stock, worth $19,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 700 57.14%

Holding current value

$19,557

Previous $44,000 65.91%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$47.74 - $65.16 $112,952 - $154,168	2,366 New	2,366 $150,000
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $51,300 - $64,420	1,000 New	1,000 $57,000
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $112,521 - $142,171	-3,377 Reduced 15.79%	18,008 $665,000
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $779,697 - $941,581	21,385 New	21,385 $816,000
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $1.44 Million - $2.14 Million	36,045 New	36,045 $2.05 Million
Q2 2022 Aug 08, 2022	SELL	$37.35 - $48.3 $21,887 - $28,303	-586 Reduced 5.29%	10,499 $462,000
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $124,203 - $159,518	3,885 Added 53.96%	11,085 $442,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $229,104 - $293,400	7,200 New	7,200 $290,000
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $189,189 - $249,931	-4,871 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $196,838 - $256,323	-4,982 Reduced 50.56%	4,871 $203,000
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $231,526 - $269,454	-15,232 Reduced 60.72%	9,853 $153,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $370,003 - $432,967	25,085 New	25,085 $431,000
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $319 - $447	-24 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $32,959 - $36,378	-1,976 Reduced 98.8%	24 $0
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $33,740 - $40,600	2,000 New	2,000 $34,000
Q4 2017 Feb 14, 2018	SELL	$16.75 - $20.8 $363,475 - $451,360	-21,700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $254,016 - $375,839	21,600 Added 21600.0%	21,700 $377,000
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $1,000

Others Institutions Holding HALO

# of Institutions

631

Shares Held

127M

Call Options Held

408K

Put Options Held

384K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.08B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account

Walleye Trading LLC Halozyme Therapeutics, Inc. Transaction History